122 related articles for article (PubMed ID: 38840915)
1. Differences in IDO1
Malik AE; Slauenwhite D; McAlpine SM; Hanly JG; Marshall JS; Issekutz TB
Front Immunol; 2024; 15():1352251. PubMed ID: 38840915
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis.
Cooles FAH; Anderson AE; Skelton A; Pratt AG; Kurowska-Stolarska MS; McInnes I; Hilkens CMU; Isaacs JD
Front Immunol; 2018; 9():755. PubMed ID: 29867920
[TBL] [Abstract][Full Text] [Related]
3. Association of a Type 2-Polarized T Cell Phenotype With Methotrexate Nonresponse in Patients With Rheumatoid Arthritis.
Slauenwhite D; McAlpine SM; Hanly JG; Malik A; Haidl ID; Marshall JS; Issekutz TB
Arthritis Rheumatol; 2020 Jul; 72(7):1091-1102. PubMed ID: 32039570
[TBL] [Abstract][Full Text] [Related]
4. Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy.
Kavousanaki M; Makrigiannakis A; Boumpas D; Verginis P
Arthritis Rheum; 2010 Jan; 62(1):53-63. PubMed ID: 20039433
[TBL] [Abstract][Full Text] [Related]
5. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
[TBL] [Abstract][Full Text] [Related]
6. An immunological biomarker to predict MTX response in early RA.
Ponchel F; Goëb V; Parmar R; El-Sherbiny Y; Boissinot M; El Jawhari J; Burska A; Vital EM; Harrison S; Conaghan PG; Hensor E; Emery P
Ann Rheum Dis; 2014 Nov; 73(11):2047-53. PubMed ID: 23989988
[TBL] [Abstract][Full Text] [Related]
7. High serum level of haptoglobin is associated with the response of 12 weeks methotrexate therapy in recent-onset rheumatoid arthritis patients.
Tan W; Wang F; Guo D; Ke Y; Shen Y; Lv C; Zhang M
Int J Rheum Dis; 2016 May; 19(5):482-9. PubMed ID: 24863583
[TBL] [Abstract][Full Text] [Related]
8. Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis.
Chara L; Sánchez-Atrio A; Pérez A; Cuende E; Albarrán F; Turrión A; Chevarria J; Sánchez MA; Monserrat J; de la Hera A; Prieto A; Sanz I; Diaz D; Alvarez-Mon M
Arthritis Res Ther; 2012 Jul; 14(4):R175. PubMed ID: 22838733
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis.
Cribbs AP; Kennedy A; Penn H; Amjadi P; Green P; Read JE; Brennan F; Gregory B; Williams RO
Arthritis Rheumatol; 2015 May; 67(5):1182-92. PubMed ID: 25604080
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of activating Fcgamma receptors on monocytes of patients with rheumatoid arthritis upon methotrexate treatment.
Wijngaarden S; van Roon JA; van de Winkel JG; Bijlsma JW; Lafeber FP
Rheumatology (Oxford); 2005 Jun; 44(6):729-34. PubMed ID: 15757966
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of methotrexate on the increased CCR2 density on circulating CD4 T lymphocytes and monocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in responders.
Ellingsen T; Hornung N; Møller BK; Poulsen JH; Stengaard-Pedersen K
Ann Rheum Dis; 2007 Feb; 66(2):151-7. PubMed ID: 16905577
[TBL] [Abstract][Full Text] [Related]
12. FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy.
Cooper DL; Martin SG; Robinson JI; Mackie SL; Charles CJ; Nam J; ; Isaacs JD; Emery P; Morgan AW
PLoS One; 2012; 7(1):e28918. PubMed ID: 22235253
[TBL] [Abstract][Full Text] [Related]
13. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y
Front Immunol; 2018; 9():2228. PubMed ID: 30319663
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
15. The number of circulating monocytes as biomarkers of the clinical response to methotrexate in untreated patients with rheumatoid arthritis.
Chara L; Sánchez-Atrio A; Pérez A; Cuende E; Albarrán F; Turrión A; Chevarria J; del Barco AA; Sánchez MA; Monserrat J; Prieto A; de la Hera A; Sanz I; Diaz D; Alvarez-Mon M
J Transl Med; 2015 Jan; 13():2. PubMed ID: 25592233
[TBL] [Abstract][Full Text] [Related]
16. In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4(+) T lymphocytes.
Ellingsen T; Hornung N; Møller BK; Hjelm-Poulsen J; Stengaard-Pedersen K
Scand J Immunol; 2007 Oct; 66(4):451-7. PubMed ID: 17850590
[TBL] [Abstract][Full Text] [Related]
17. Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3-dioxygenase 1 with functional effects on T cell priming.
Sittig SP; van Beek JJP; Flórez-Grau G; Weiden J; Buschow SI; van der Net MC; van Slooten R; Verbeek MM; Geurtz PBH; Textor J; Figdor CG; de Vries IJM; Schreibelt G
Eur J Immunol; 2021 Jun; 51(6):1494-1504. PubMed ID: 33675038
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate Treatment Suppresses Monocytes in Nonresponders to Pneumococcal Conjugate Vaccine in Rheumatoid Arthritis Patients.
Elmér E; Nived P; Pettersson Å; Skattum L; Hellmark T; Kapetanovic MC; Johansson ÅCM
J Immunol Res; 2022; 2022():7561661. PubMed ID: 35935581
[TBL] [Abstract][Full Text] [Related]
19. The Abnormal CD4+T Lymphocyte Subset Distribution and Vbeta Repertoire in New-onset Rheumatoid Arthritis Can Be Modulated by Methotrexate Treament.
Monserrat J; Bohórquez C; Gómez Lahoz AM; Movasat A; Pérez A; Ruíz L; Díaz D; Chara L; Sánchez AI; Albarrán F; Sanz I; Álvarez-Mon M
Cells; 2019 Aug; 8(8):. PubMed ID: 31405169
[TBL] [Abstract][Full Text] [Related]
20. Blood PD-1+TFh and CTLA-4+CD4+ T cells predict remission after CTLA-4Ig treatment in early rheumatoid arthritis.
Aldridge J; Andersson K; Gjertsson I; Hultgård Ekwall AK; Hallström M; van Vollenhoven R; Lundell AC; Rudin A
Rheumatology (Oxford); 2022 Mar; 61(3):1233-1242. PubMed ID: 34009274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]